Stock HBIO HARVARD BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Harvard Bioscience, Inc.

Equities

HBIO

US4169061052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
3.07 USD -1.92% Intraday chart for Harvard Bioscience, Inc. -0.97% -42.62%
May. 07 Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07 Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Benchmark Adjusts Price Target on Harvard Bioscience to $7 From $4, Maintains Buy Rating
MT
Keybanc Adjusts Price Target on Harvard Bioscience to $7 From $5, Maintains Overweight Rating
MT
KeyBanc Capital Markets Trims Price Target on Harvard Bioscience to $5 From $7, Maintains Overweight Rating
MT
KeyBanc Capital Markets Trims Price Target on Harvard Bioscience to $7 From $10, Keeps Overweight Rating
MT
HARVARD BIOSCIENCE : Northland Capital Starts Harvard Bioscience at Outperform With $6 Price Target
MT
HARVARD BIOSCIENCE : KeyBanc Initiates Harvard Bioscience at Overweight with $6 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HBIO Stock
  4. News Harvard Bioscience, Inc.
  5. Analyst Reco.